Shopping Cart
- Remove All
- Your shopping cart is currently empty
IDO-IN-7 (NLG-919 analogue) is a potent inhibitor of the IDO (indoleamine-(2, 3)-dioxygenase) pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $38 | In Stock | |
5 mg | $58 | In Stock | |
10 mg | $95 | In Stock | |
25 mg | $153 | In Stock | |
50 mg | $252 | In Stock | |
100 mg | $450 | In Stock | |
500 mg | $987 | In Stock | |
1 mL x 10 mM (in DMSO) | $58 | In Stock |
Description | IDO-IN-7 (NLG-919 analogue) is a potent inhibitor of the IDO (indoleamine-(2, 3)-dioxygenase) pathway. |
Targets&IC50 | IDO:75 nM(EC50) |
In vitro | In mice bearing B16F10 tumors, NLG919 significantly enhanced the antitumor response of pmel-1 resting cells to homologous hgp100 peptide and CpG-1826. |
In vivo | NLG919 effectively blocks the IDO-induced suppression of T-cell responses, restoring T-cell activity (ED50=80 nM). In mouse dendritic cells (DCs) expressing IDO from tumor lymph nodes (ED50=120 nM), NLG919 abolishes the IDO-induced inhibition of antigen-specific T-cells (OT-1). |
Alias | NLG-919 analogue, Navoximod analogue, GDC-0919 analogue |
Molecular Weight | 282.38 |
Formula | C18H22N2O |
Cas No. | 1402836-58-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | Ethanol: 26 mg/mL (92.1 mM) DMSO: 45 mg/mL (159.36 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.